Zhongzhu Medical Holdings Co Ltd (600568) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.78 Million ≈ $3.92 Million USD) by net assets (CN¥1.71 Billion ≈ $250.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhongzhu Medical Holdings Co Ltd (600568) total market value for the company's overall valuation and market capitalisation.

Zhongzhu Medical Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Zhongzhu Medical Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhongzhu Medical Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their cash flow conversion efficiency. Explore 600568 cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
CEWE Stiftung & Co. KGaA
XETRA:CWC
-0.010x
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590
0.027x
Xingtong Shipping Co. Ltd.
SHG:603209
N/A
indie Semiconductor Inc
NASDAQ:INDI
-0.090x
Daqo New Energy Corp
F:5DQ2
-0.022x
Shenyang Jinbei Automotive Co Ltd
SHG:600609
0.204x
Beijing North Star Co Ltd Class A
SHG:601588
0.076x
Zhejiang Anglikang Pharmaceutical Co Ltd Class A
SHE:002940
0.059x

Annual Cash Flow Conversion Efficiency for Zhongzhu Medical Holdings Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Zhongzhu Medical Holdings Co Ltd from 1999 to 2025. View 600568 live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.63 Billion
≈ $238.63 Million
CN¥56.08 Million
≈ $8.21 Million
0.034x +83.70%
2024-12-31 CN¥1.74 Billion
≈ $255.02 Million
CN¥32.63 Million
≈ $4.77 Million
0.019x +1649.82%
2023-12-31 CN¥2.59 Billion
≈ $379.07 Million
CN¥2.77 Million
≈ $405.57K
0.001x -87.69%
2022-12-31 CN¥2.94 Billion
≈ $429.73 Million
CN¥25.52 Million
≈ $3.74 Million
0.009x -65.54%
2021-12-31 CN¥3.73 Billion
≈ $545.62 Million
CN¥94.04 Million
≈ $13.76 Million
0.025x -59.55%
2020-12-31 CN¥3.98 Billion
≈ $582.38 Million
CN¥248.15 Million
≈ $36.31 Million
0.062x -60.51%
2019-12-31 CN¥3.89 Billion
≈ $569.54 Million
CN¥614.57 Million
≈ $89.93 Million
0.158x +351.03%
2018-12-31 CN¥4.26 Billion
≈ $622.92 Million
CN¥-267.76 Million
≈ $-39.18 Million
-0.063x -7.91%
2017-12-31 CN¥6.15 Billion
≈ $899.41 Million
CN¥-358.29 Million
≈ $-52.43 Million
-0.058x -218.18%
2016-12-31 CN¥6.01 Billion
≈ $879.82 Million
CN¥296.58 Million
≈ $43.40 Million
0.049x -30.98%
2015-12-31 CN¥2.65 Billion
≈ $387.06 Million
CN¥189.05 Million
≈ $27.66 Million
0.071x +1185.81%
2014-12-31 CN¥2.58 Billion
≈ $377.47 Million
CN¥14.34 Million
≈ $2.10 Million
0.006x +84.24%
2013-12-31 CN¥1.18 Billion
≈ $172.51 Million
CN¥3.56 Million
≈ $520.44K
0.003x +106.40%
2012-12-31 CN¥1.03 Billion
≈ $150.39 Million
CN¥-48.43 Million
≈ $-7.09 Million
-0.047x +42.30%
2011-12-31 CN¥915.88 Million
≈ $134.02 Million
CN¥-74.80 Million
≈ $-10.94 Million
-0.082x +88.58%
2010-12-31 CN¥742.77 Million
≈ $108.69 Million
CN¥-531.24 Million
≈ $-77.74 Million
-0.715x -91.30%
2009-12-31 CN¥677.27 Million
≈ $99.11 Million
CN¥-253.20 Million
≈ $-37.05 Million
-0.374x -353.89%
2008-12-31 CN¥616.24 Million
≈ $90.17 Million
CN¥90.74 Million
≈ $13.28 Million
0.147x +2020.96%
2007-12-31 CN¥514.98 Million
≈ $75.36 Million
CN¥3.58 Million
≈ $523.18K
0.007x -93.14%
2006-12-31 CN¥479.24 Million
≈ $70.13 Million
CN¥48.49 Million
≈ $7.10 Million
0.101x -1.27%
2005-12-31 CN¥558.76 Million
≈ $81.76 Million
CN¥57.27 Million
≈ $8.38 Million
0.102x +1726.33%
2004-12-31 CN¥489.48 Million
≈ $71.63 Million
CN¥2.75 Million
≈ $401.95K
0.006x +380.94%
2003-12-31 CN¥472.91 Million
≈ $69.20 Million
CN¥551.80K
≈ $80.75K
0.001x -8.44%
2002-12-31 CN¥444.66 Million
≈ $65.07 Million
CN¥566.66K
≈ $82.92K
0.001x -87.95%
2001-12-31 CN¥433.47 Million
≈ $63.43 Million
CN¥4.59 Million
≈ $671.09K
0.011x -69.40%
2000-12-31 CN¥82.36 Million
≈ $12.05 Million
CN¥2.85 Million
≈ $416.77K
0.035x -64.08%
1999-12-31 CN¥69.76 Million
≈ $10.21 Million
CN¥6.72 Million
≈ $982.65K
0.096x --

About Zhongzhu Medical Holdings Co Ltd

SHG:600568 China Drug Manufacturers - Specialty & Generic
Market Cap
$696.97 Million
CN¥4.76 Billion CNY
Market Cap Rank
#10741 Global
#2966 in China
Share Price
CN¥2.39
Change (1 day)
-1.24%
52-Week Range
CN¥1.82 - CN¥3.21
All Time High
CN¥9.91
About

Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers Ophthalmic drugs, including pearl brightening eye drops, clindamycin phosphate for injection, acyclovir dispersible tablets, sodium cromoglycate eye drops, acyclovir for injection, diclofenac sodium suppositories, diclofenac sodium liniment, azithromycin granules… Read more